Utrecht-based Vitestro has raised €20mn to bring its robotic blood drawing device to market. Founded in 2017, Vitestro aims to improve the blood draw experience for patients and address personnel shortages in healthcare — where the demand for skilled laboratory professionals is growing at a higher rate than any other occupation. The startup’s device relies on infrared to locate the vein and ultrasound to create an image of the blood vessel. Then, an AI-based robotic needle uses this information to determine the right puncture location with submillimetre precision. Since 2023, Vitestro is running the world’s largest-scale clinical trial for autonomous…
This story continues at The Next Web
